Skip to main content

Published locations for Extended-release amantadine approved for treatment of dyskinesia in Parkinson’s

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Extended-release amantadine approved for treatment of dyskinesia in Parkinson’s

User login

  • Reset your password
  • /content/extended-release-amantadine-approved-treatment-dyskinesia-parkinsons
  • /familypracticenews/article/145392/movement-disorders/extended-release-amantadine-approved-treatment
  • /internalmedicinenews/article/145392/movement-disorders/extended-release-amantadine-approved
  • /psychiatry/article/145392/movement-disorders/extended-release-amantadine-approved-treatment
  • /internalmedicine/article/145392/movement-disorders/extended-release-amantadine-approved-treatment
  • /neurology/article/145392/movement-disorders/extended-release-amantadine-approved-treatment
  • /familymedicine/article/145392/movement-disorders/extended-release-amantadine-approved-treatment
  • /clinicalneurologynews/article/145392/movement-disorders/extended-release-amantadine-approved
  • /clinicalpsychiatrynews/article/145392/movement-disorders/extended-release-amantadine-approved